GSK acquires full rights to mRNA candidate vaccines
GSK acquires full rights to develop, manufacture and commercialise globally mRNA candidate vaccines for influenza and COVID-19, including combinations...
AstraZeneca reports strong growth in 2023 despite COVID-19 challenges
AstraZeneca, a global biopharmaceutical company, announced its financial results for the full year 2023, showing a 6% increase in total revenue and a 15% increase...
Data shows SARS-CoV-2 human challenge studies safe in healthy young adults
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge...
Pakistanis can’t meet life-goals due to ‘Confidence Gap’
Standard Chartered latest survey into affluent (comprising emerging affluent, affluent and high net worth) consumers in 12 markets across Asia, Africa, the Middle East and...
Spiritus Mundi intends IPO on London Stock Exchange
LONDON, UK: Special purpose acquisition vehicle, Spiritus Mundi, intends to launch an initial public offering (IPO) on the Main Market of the London Stock Exchange....
Kingmaker Footwear resumes production at Vietnam factory
HONG KONG: Kingmaker Footwear Holdings Limited has resumed production at the group’s factory in Binh Duong Province, Vietnam. Kingmaker Footwear had earlier notified temporary production halt at...
LNG demand set for growth as global economies recover
LONDON: Global liquefied natural gas (LNG) trade increased to 360 million tonnes in 2020, according to Shell’s latest annual LNG Outlook published today, despite the...
Property and casualty insurers report 27.5% drop in net income during first nine months of 2020
JERSEY CITY: The private U.S. property and casualty (P&C) insurance industry’s net income after taxes dropped 27.5 percent to $35.1 billion in the first nine...
U.S. FDA approves Gilead’s antiviral Veklury (remdesivir) for treatment of COVID-19
FOSTER CITY: Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment...
AstraZeneca’s COVID-19 long-acting antibody combination advances into Phase III clinical trials
LONDON: AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside...
Oncimmune announces UK Government funding for tool for use in COVID-19
LONDON: Oncimmune Holdings announced the award of funding from the ‘UK Research and Innovation (UKRI) Ideas to Address COVID-19’ programme, to support a joint collaboration...
Synairgen and Clinigen sign agreement for treatment of hospitalised patients with COVID-19
SOUTHAMPTON: Synairgen plc and Clinigen Group have signed an agreement to launch a Managed Access Program for Synairgen’s inhaled formulation of interferon beta (IFN-beta), SNG001,...